Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles

Journal of Infectious Diseases

Volumn 186, Issue 6, 2002, Pages 737-742

  Ho, Gloria Y F ^a   Studentsov, Yevgeniy ^a   Hall, Charles B ^a   Bierman, Robert ^b   Beardsley, Leah ^b   Lempa, Michele ^b   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; ORAL CONTRACEPTIVE AGENT; VIRUS ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNITY; INCIDENCE; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; UTERINE CERVIX CYTOLOGY; VAGINITIS; VERRUCA VULGARIS; VIRUS PARTICLE; WART VIRUS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CERVIX UTERI; CONTRACEPTIVES, ORAL; ETHNIC GROUPS; FEMALE; GENES, VIRAL; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; TUMOR VIRUS INFECTIONS; VAGINA;

EID: 0037105643     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/342972     Document Type: Article

References (28)

1. Risk factors for cervical cancer in Colombia and Spain
2. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
3. Natural history of cervicovaginal papillomavirus infection in young women
4. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
5. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
6. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy
7. Sexual behavior and partner characteristics are the predominant risk factors for genital HPV infection in young women
8. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: Correlation with biopsy results and Papanicolaou smear
9. Quantitative disassembly and reassembly of human papillomavirus type 11 virus like particles in vitro
10. Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus
11. Proportional hazards tests and diagnostics based on weighted residuals
12. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: Are there different risk profiles for oncogenic and nononcogenic HPV types?
13. Oral contraceptives and papillomavirus persistence in normal cervix
14. Determinants of genital human papillomavirus infection in young women
15. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia
16. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives
17. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and -negative women
18. Animal models for human papillomavirus vaccine development
19. Immunological analyses of human papillomavirus capsids
20. In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16
21. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition
22. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16
23. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions
24. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
25. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women